Mainz Biomed N.V. (MYNZ) Profit Margin (2019 - 2025)
Mainz Biomed N.V. (MYNZ) profit margin from Dec 31, 2019 to Dec 31, 2025. The current Mainz Biomed N.V. (MYNZ) profit margin is -3001.85%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Annual Profit Margin change of Mainz Biomed N.V. (MYNZ)
| Year | Profit Margin | Change |
|---|---|---|
| 2025 | -3001.85% | +23.69% |
| 2024 | -2426.97% | -0.23% |
| 2024 | -2432.58% | -16.76% |
| 2023 | -2922.22% | -41.31% |
| 2022 | -4979.25% | +147.05% |
| 2021 | -2015.52% | +1573.90% |
| 2020 | -120.41% | -64.88% |
| 2019 | -342.86% | N/A |
Comparison Mainz Biomed N.V. (MYNZ) profit margin with competitors
Mainz Biomed N.V. (MYNZ) profit margin is -3001.85%.
| Ticker | Name | Profit Margin | Upside |
|---|---|---|---|
| IDXX | Idexx Laboratories Inc | 24.41% | -100.81% |
| VCYT | Veracyte Inc | 20.64% | -100.69% |
| QGEN | Qiagen NV | 20.33% | -100.68% |
| A | Agilent Technologies Inc | 18.47% | -100.62% |
| MTD | Mettler-Toledo International Inc | 17.89% | -100.60% |
| MEDP | Medpace Holdings Inc | 17.53% | -100.58% |
| DHR | Danaher Corp | 17.29% | -100.58% |
| BLLN | Billiontoone Inc - Class A | 16.58% | -100.55% |
| TMO | Thermo Fisher Scientific Inc | 15.00% | -100.50% |
| ILMN | Illumina Inc | 12.28% | -100.41% |
| SHC | Sotera Health Company | 9.49% | -100.32% |
| DGX | Quest Diagnostics Inc | 8.70% | -100.29% |
| LH | Laboratory Corp Of America Holdings | 7.85% | -100.26% |
| IQV | IQVIA Holdings Inc | 6.60% | -100.22% |
| FONR | Fonar Corp | 6.20% | -100.21% |
| RVTY | Revvity Inc | 5.73% | -100.19% |
| ICLR | Icon Plc | 2.78% | -100.09% |
| CDNA | Caredx Inc | 2.39% | -100.08% |